ABSTRACT--Hirame rhabdovirus (HIRRV) was first reported from flounder (Paralichthys olivaceus) in Japan, and has recently been isolated from an aquaculture farm in the Tongyoung area of Korea. Total RNA isolated from RTG-2 cells infected with HIRRV was used in RT-PCR to obtain a cDNA coding for the glycoprotein of HIRRV Korean strain, CA-9703. Around half sized G protein in the C-terminal region was expressed as glutathione-S-transferase fusion protein, and used as viral vaccine against HIRRV. Flounder fry were vaccinated with low and high doses of vaccine by immersing them for 7 min in vaccine solution.
Although vaccines have been developed for several important pathogens, vaccination against fish viral dis eases has been limited primarily because of high pro duction costs and problems with the logistics of vaccinat ing large populations of fish (Leong, 1993) . However, a recent development in molecular biology has made it possible to produce a large amount of recombinant viral protein as a sub-unit vaccine that can be used for vacci nation by immersion or injection of individual fish (Munn, 1994; Lorenzen, 1999) . In addition, viral genes cloned into an expression vector and introduced into fish tissue as DNA vaccines have been proved to be effective in in door experiments and small-scale field experiments (Corbeil et al., 1999; Kim et al., 2000) .
The pathogenic rhabdovirus of fish, hirame rhab dovirus (HIRRV), was first isolated from Japanese flounder (Paralichthys olivaceus) and ayu fish (Plecoglossus altivelis) (Kimura et al., 1986) . Subsequently, HIRRV was isolated from diseased flounder in Korea (Oh and Choi, 1998) . The clinical sign of HIRRV infection is septicemia that manifests as severe bleedina of internal organs. The electrophoresis pattern of structural proteins originally suggested that HIRRV was closely related to viruses of the genus Lyssavirus (Nishizawa et al., 1991) . More recently, it has been classified as belonging to the genus Novirhabdovirus, family Rhabdoviridae (van Regenmortel et al., 2000) . Kurath et al. (1985) reported that the HIRRV genome consists of approximately 11,000 bases encoding six viral proteins: RNA polymerase, envelope glycoprotein (G), nucleo capsid protein, two matrix proteins, and non-viral protein.
The glycoprotein is a spike protein that spans the viral envelope and protrudes towards the exterior of the virion (Bjorklund et al., 1996) . This protein is the antigen that determines the serological properties of a rhabdovirus and functions as the antigen eliciting neu tralization antibody (Hill et al., 1975) . The glycoproteins of vesicular stomatitis virus (VSV) and rabies virus are also responsible for eliciting both neutralizing antibody and protective immune responses (Kelly et al., 1972; Witkor et al., 1984) . In the infectious hematopoietic necrosis virus (IHNV), the G protein is the only viral protein necessary to elicit neutralizing antibody (Engelking and Leong, 1989) . It has also been reported that an antigenic determinant of the glycoprotein gene of IHNV expressed as fusion protein with trpE protein of Escheri chia coli induced protective immunity (Gilmore et al., 1988) . Recent studies on DNA vaccines for fish rhab dovirus glycoprotein also shown that the glycoprotein is sufficient to induce protective immunity against the cor responding virus and even other rhabdoviruses in the same genus (Corbeil et al., 1999; Kim et al., 2000) .
Recently, our laboratory has cloned and sequenced the whole genome of a Korean strain of HIRRV that con sists of 11034 nucleotides (Oh, 2000) . In the present study, we expressed the C-terminal portion of HIRRV glycoprotein as a glutathione-s-transferase (GST)-glyco protein fusion protein and evaluated the protective immunogenicity of the purified fusion protein.
Materials
and Methods Expression of GST-glycoprotein fusion protein Around one half of the G protein in the C-terminal region was expressed as GTS-glycoprotein fusion protein.
Cell and virus
The pGTHRG was digested with EcoRI and Xhol, and an 800 bp DNA fragment encompassing 260 amino acids at the C-terminal was cloned into the pGEX4T-1 vector. The E. coli BL21 (DE3) strain was transformed with the resulting clone pECHRG. The transformed E. coli was cultured in LB broth containing ampicillin (100 ,ug/mL). The cells were induced with IPTG at a final concentration of 1 mM after the OD600 reached 0.5. Three milliliters of cell suspension were harvested at 2, 4, and 6 h after induction, and the protein was analyzed by SDS-PAGE using 12.5% polyacryla mide gels. Fig. 1 . SDS-PAGE analysis of GST-G fusion protein expressed in E. coli. Lane M: broad range molecular weight protein size marker, Lane S: un-induced E. coli extract, Lanes 1-3: extracts of E. coli harboring GST-G fusion after 2, 4, and 6 h induction, respectively, Lane 4: purified GST-G fusion protein. Fish mortalities after immersion infection were 1.7% and 0% for the high and low doses, respectively.
Post-mortem analysis was carried out to confirm that mortality was due to infection with HIRRV. Fish showing typical HIRRV symptoms, including hemorrhage and accumulation of ascitic fluid, were considered as having been killed by viral infection, and all except for three fish in the high dose vaccine group that were used as a positive control in RT-PCR, were not tested further. Dead fish that did not show any specific symptoms were tested for the presence of HIRRV by RT-PCR. As shown in Fig. 2 , HIRRV was detected from all three dead fish in the high dose vaccinated group and from four out of six in the non-vaccinated group. Interestingly, HIRRV was not detected in dead fish from the low dose vaccine group that did not show any clinical symptoms.
Discussion
The entire G protein was not expressed in E. coli and one possible explanation for this is the toxicity of expressed glycoprotein in E. coll. It is known that a short (less than 15 amino acids) stretch of hydrophobic amino acid residues occurs in the signal peptide sequence or transmembrane anchor domain (Brosius, 1984; Steinberg et al., 1995) . The signal peptide sequences of many viral glycoproteins have been implicated as possible causes of host toxicity and low expression level in E. coli (Brosius, 1984; Steinberg et al., 1995) . The signal sequence and transmembrane domain have also been identified from the G protein of HIRRV (Bjorklund et al., 1996) . There are several reports of the use of recombinant glycoprotein vaccines against fish rhabdoviruses, and most of those were expressed as fusion proteins (Gilmore et The numbers in each group indicate individual dead fish.
Another consideration with the GST-G fusion protein vaccine is the vaccination effect of non-glycosylated protein expressed in E. coli. Glycosylation is generally considered to be important for proper activity of viral vaccines.
However, trpE fusion protein of IHNV glyco protein expressed in E. coli induced protective immunity, whereas G protein expressed in insect cells failed to in duce antibody-mediated protection in trout fry (Gilmore et al., 1988; Cain et al., 1999) . Furthermore, the GST-G fusion protein was purified from a denaturing acrylamide gel and was not renatured before applica tion.This suggests that glycosylation and conformation independent linear epitope or epitopes are responsible for the induced protective immunity against HIRRV. Linear reduction-resistant neutralizing epitopes have also been identified in rabies (Van Deer Heijden et al., 1993; Ni et al., 1995) , VSV (Keil and Wagner, 1989; Grigera et al., 1992) , and IHNV (Leong et al., 1995) .
The major problems for the application of recombi nant sub-unit vaccine in aquaculture are the low efficacy and the high cost of mass production (Winton, 1997) . Further attempts are under way to produce a cost-effec tive and biologically active vaccine using a eukaryotic expression system developed in our laboratory, and to conduct field experiments.
